Dipyridamole-mediated reversal of multidrug resistance in MRP over- expressing human lung carcinoma cells in vitro

European Journal of Cancer

Volumn 35, Issue 6, 1999, Pages 1020-1026

  Curtin, N J ^a   Turner, D P ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Dipyridamole; Glutathione; Multidrug resistance associated protein (MRP); Resistance modulation; VP16 (etoposide)

Indexed keywords

DIPYRIDAMOLE; DOXORUBICIN; ETOPOSIDE; GLUTATHIONE; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIZATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CELL DIVISION; DIPYRIDAMOLE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; HUMANS; LUNG NEOPLASMS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PHOSPHODIESTERASE INHIBITORS; TUMOR CELLS, CULTURED;

EID: 0033152176     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00038-6     Document Type: Article

References (38)

1. Endicott J.A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann Rev Biochem. 58:1989;137-171.
2. Cole S.P.C., Bhardwaj G., Gerlach J.H.et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
3. Grant C.E., Valdimarsson G., Hipfner D.R., Almquist K.C., Cole S.P.C., Deeley R.G. Overexpression of multidrug resistance associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54:1994;357-361.
4. Lorico A., Rappa G., Flavell R.A., Sartorelli A.C. Double knockout of the MRP gene leads to increased drug sensitivity in vitro. Cancer Res. 56:1996;5351-5355.
5. Wijnholds J., Evers R., Van Leusden M.R.et al. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nature Med. 3:1997;1275-1279.
6. Lautier D., Canitrot Y., Deeley R.G., Cole S.P.C. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem Pharmacol. 52:1996;967-977.
7. Kruh G.D., Gaughan K.T., Goodwin A., Chan A. Expression pattern of MRP in human tissues and adult solid tumour cell lines. J Natl Cancer Inst. 87:1995;1256-1258.
8. Izquierdo M.A., Shoemaker R.H., Flens M.J.et al. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int J Cancer. 65:1996;230-237.
9. Harvie R.M., Davey M.W., Davey R.A. Increased MRP expression is associated with resistance to radiation, anthracyclins and etoposide in cells treated with fractionated gamma-radiation. Int J Cancer. 73:1997;164-167.
10. Ota E., Abe Y., Oshika Y.et al. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br J Cancer. 72:1995;550-554.
11. Berger W., Hauptmann E., Elbling L., Vetterlein M., Kokoschka E.M., Micksche M. Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells. Int J Cancer. 71:1997;108-115.
12. Nooter K., Brutel D.E., La Riviere G.et al. The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer. Br J Cancer. 76:1997;486-493.
13. Bordow S.B., Haber M., Madafiglio J., Cheung B., Marshall G.M., Norris M.D. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of N-myc oncogene in childhood neuroblastoma. Cancer Research. 44:1994;5036-5040.
14. Wigler P.W., Patterson F.K. Inhibition of the multidrug resistance efflux pump. Biochim et Biophys Acta. 1154:1993;173-181.
15. Jedlitschky G., Leier I., Buchholz U., Barnouin K., Kurz G., Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene encoded conjugate export pump. Cancer Res. 56:1996;988-994.
16. Twentyman P.R., Versantvoort C.H.M. Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance. Eur J Cancer. 32A:1996;1002-1009.
17. Versantvoort C.H.M., Bagrij T., Wright K.A., Twentyman P.R. On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int J Cancer. 63:1995;855-962.
18. Plagemann P.G.W., Wohlhueter R.M., Woffendin C. Nucleoside and nucleobase transport in animal cells. Biochim et Biophys Acta. 947:1988;405-443.
19. Goel R, Howell SB. Modulation of the activity of cancer chemotherapeutic agents by dipyridamole. In Muggia FM, (ed). New Drugs, Concepts and Results in Cancer Chemotherapy. Boston, Massachusetts, Kluwer Acad. 1992, 19-44.
20. Asoh K-I., Yoshio S., Sato S-I., Nogae I., Kohno K., Kuwano M. Potentiation of some anticancer agents by dipyridamole against drug-sensitive and drug-resistant cancer cell lines. Jpn J Cancer Res. 80:1990;475-481.
21. Howell S.B., Hom D., Sanga R., Vick J.S., Chan T.K.C. Dipyridamole enhancement of etoposide sensitivity. Cancer Res. 49:1989;4147-4153.
22. Shalinsky D.R., Andreeff M., Howell S.B. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumour cells in vitro. Cancer Res. 50:1990;7537-7543.
23. Turner R.N., Curtin N.J. Dipyridamole increases VP16 growth inhibition, accumulation and retention in parental and multidrug-resistant CHO cells. Br J Cancer. 73:1996;856-860.
24. Twentyman P.R., Fox N.E., Wright K.A., Bleehen N. Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells. Br J Cancer. 53:1986;529-537.
25. Coley H.M., Workman P., Twentyman P.R. Retention of activity by selected anthracyclines in a multidrug resistant large cell lung carcinoma line without P-glycoprotein hyperexpression. Br J Cancer. 63:1991;351-357.
26. Barrand M.A., Rhodes T., Center M.S., Twentyman P.R. Chemosensitisation and drug accumulation effects of cyclosporin A PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. Eur J Cancer. 29A:1993;408-419.
27. Skehan P., Storeng R., Scudiero D.et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 82:1990;1107-1112.
28. Baker M.A., Cerniglia G.J., Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem. 190:1990;360-365.
29. Kearns PR, Hall AG. Methods in Molecular Biology: Cytotoxic Drug Resistance Mechanisms. Totowa, New Jersey, Humana Press, 1999, in press.
30. Grech K.V., Davey R.A., Davey M.W. The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukaemia cells. Biochem Pharmacol. 55:1998;1283-1289.
31. Versantvoort C.H.M., Broxterman H.J., Bagrij T., Scheper R.J., Twentyman P.R. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer. 72:1995;82-89.
32. Draper M.P., Martell R.L., Levy S.B. Indomethacin mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. Br J Cancer. 75:1997;810-815.
33. O'Brien M., Paul S., Kruh G., Tew K. Modulators of glutathione and glutathione-S-transferase in multidrug resistance-associated protein (MRP) overexpressing cells. Proc Soc Amer Assoc Cancer Res. 38:1997;441.
34. Jekunen A., Vick J., Sanga R., Chan T.C.K., Howell S.B. Synergism between dipyridamole and cisplatin in ovarian carcinoma cells in vitro. Cancer Res. 52:1992;3566-3571.
35. Okudaira K., Yachi K., Sawada Y., Sugiyama Y., Iga T., Hanano M. Effect of basic drugs on the hepatic uptake of ouabain by sinusoidal plasma membrane vesicles isolated from rat liver. Biopharmaceutics and Drug Disposition. 13:1992;295-304.
36. Cabral S., Leis S., Bover L., Nembrot M., Mordoh J. Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells. Proc Natl Acad Sci USA. 81:1984;3200-3203.
37. Hooijberg J.H., Heijn M., Fles D.L.A., Lankelma J., Pinedo H.M., Broxterman H.J. Substrate interaction and ATPase activity of multidrug resistance protein (MRP). Proc Amer Assoc Cancer Res. 38:1997;392.
38. Tatsuta T., Shimizu K., Nishimura T., Suzuki H. Enhancement of activities of antitumour drugs by dipyridamole against multidrug-resistant human hepatoma PLC/PRF/5 cells. Anti-Cancer Drug Design. 6:1991;179-188.